Prostaglandin E inhibition of mitogen stimulation in patients with multiple sclerosis

James Goodwin, Ronald P. Messner

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Kirbey et al have reported that leukocyte function from patients with multiple sclerosis is not suppressed by PGE2, as are normal leukocytes. We examined the ability of PGE2 (0.01-0.5 μg/ml) to suppress Phytohemagglutinin induced 3H-thymidine incorporation in peripheral blood lymphocytes from multiple sclerosis patients and normals. There was no difference in sensitivity between the two groups. There was also no difference in activity of the prostaglandin producing suppressor cell between the multiple sclerosis patients and controls.

Original languageEnglish (US)
Pages (from-to)281-286
Number of pages6
JournalProstaglandins
Volume15
Issue number2
DOIs
StatePublished - 1978
Externally publishedYes

Fingerprint

Prostaglandins E
Mitogens
Dinoprostone
Multiple Sclerosis
Lymphocytes
Phytohemagglutinins
Leukocytes
Thymidine
Prostaglandins
Blood

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology

Cite this

Prostaglandin E inhibition of mitogen stimulation in patients with multiple sclerosis. / Goodwin, James; Messner, Ronald P.

In: Prostaglandins, Vol. 15, No. 2, 1978, p. 281-286.

Research output: Contribution to journalArticle

@article{5494567ae3834f09ae1d44305ffe4a1c,
title = "Prostaglandin E inhibition of mitogen stimulation in patients with multiple sclerosis",
abstract = "Kirbey et al have reported that leukocyte function from patients with multiple sclerosis is not suppressed by PGE2, as are normal leukocytes. We examined the ability of PGE2 (0.01-0.5 μg/ml) to suppress Phytohemagglutinin induced 3H-thymidine incorporation in peripheral blood lymphocytes from multiple sclerosis patients and normals. There was no difference in sensitivity between the two groups. There was also no difference in activity of the prostaglandin producing suppressor cell between the multiple sclerosis patients and controls.",
author = "James Goodwin and Messner, {Ronald P.}",
year = "1978",
doi = "10.1016/0090-6980(78)90167-3",
language = "English (US)",
volume = "15",
pages = "281--286",
journal = "Prostaglandins and Other Lipid Mediators",
issn = "1098-8823",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Prostaglandin E inhibition of mitogen stimulation in patients with multiple sclerosis

AU - Goodwin, James

AU - Messner, Ronald P.

PY - 1978

Y1 - 1978

N2 - Kirbey et al have reported that leukocyte function from patients with multiple sclerosis is not suppressed by PGE2, as are normal leukocytes. We examined the ability of PGE2 (0.01-0.5 μg/ml) to suppress Phytohemagglutinin induced 3H-thymidine incorporation in peripheral blood lymphocytes from multiple sclerosis patients and normals. There was no difference in sensitivity between the two groups. There was also no difference in activity of the prostaglandin producing suppressor cell between the multiple sclerosis patients and controls.

AB - Kirbey et al have reported that leukocyte function from patients with multiple sclerosis is not suppressed by PGE2, as are normal leukocytes. We examined the ability of PGE2 (0.01-0.5 μg/ml) to suppress Phytohemagglutinin induced 3H-thymidine incorporation in peripheral blood lymphocytes from multiple sclerosis patients and normals. There was no difference in sensitivity between the two groups. There was also no difference in activity of the prostaglandin producing suppressor cell between the multiple sclerosis patients and controls.

UR - http://www.scopus.com/inward/record.url?scp=0018145141&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018145141&partnerID=8YFLogxK

U2 - 10.1016/0090-6980(78)90167-3

DO - 10.1016/0090-6980(78)90167-3

M3 - Article

VL - 15

SP - 281

EP - 286

JO - Prostaglandins and Other Lipid Mediators

JF - Prostaglandins and Other Lipid Mediators

SN - 1098-8823

IS - 2

ER -